Skip to content
Disclosery

EXANE DERIVATIVES: ENS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ENS, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,153 ENS shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,153 shares
    Change vs previous 13F -1,628 shares

    0.11% of the 13F portfolio, value $185,863.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 4,781 shares
    Change vs previous 13F -425 shares

    0.1% of the 13F portfolio, value $356,497.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5,206 shares
    Change vs previous 13F +2,643 shares

    0.1% of the 13F portfolio, value $411,571.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,563 shares
    Change vs previous 13F -17 shares

    0.05% of the 13F portfolio, value $190,783.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,580 shares
    Change vs previous 13F -75 shares

    0.06% of the 13F portfolio, value $248,242.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,655 shares
    Change vs previous 13F -1,370 shares

    0.07% of the 13F portfolio, value $241,063.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4,025 shares
    Change vs previous 13F +3,363 shares

    0.1% of the 13F portfolio, value $334,301.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 662 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $44,431.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).